PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Combination treatment improves response to immunotherapy for lung cancer

2024-09-25
(Press-News.org) Francis Crick Institute press release

Under strict embargo: 10:00hrs BST Wednesday 25 September 2024

Peer reviewed

Experimental study

Animals

Combination treatment improves response to immunotherapy for lung cancer

Researchers at the Francis Crick Institute, in collaboration with Revolution Medicines, have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to target non-responsive tumours.

Their findings show that targeting tumours in different ways simultaneously might increase response to treatments.

In research published today in Nature Communications, the scientists tested a combination of tool compounds in mice with lung cancer. These compounds were used to represent:

Targeted drugs which block a cancer-causing protein called KRAS G12C. These have been approved for use in lung cancer, but often fail to benefit patients in the long term because the tumours develop resistance to these medicines over time. Immunotherapy drugs. These are designed to stimulate the immune system to fight the tumour, but only 20% of people with lung cancer respond, as tumours often block immune cells from entering. The researchers combined a newly identified KRAS G12C inhibitor1, with a compound that blocks a protein called SHP2, which inhibits cancer cells and can also activate tumor immunity.

These two inhibitors were combined with an immune checkpoint inhibitor, which blocks proteins that help the cancer cells hide from the immune system.

In mice with functional immune systems, the triplet combination shrank the tumours and, in some mice, fully eradicated them. These mice were also more resistant to the lung cancer coming back after treatment.

The team believe that these targeted compounds provide a window of opportunity where the immune checkpoint inhibitor can kick into gear and allow the body’s natural defences to attack the tumour.

Even in mice with ‘immune cold’ tumours that are normally unresponsive to immunotherapy, the combination allowed tumours to become sensitised to the immune checkpoint inhibitors.

Given the success in studies with mice, an evaluation of the combination could be conducted in people with lung cancer to determine if it has a similar effect. Research will also be needed to understand and counteract potential side effects associated with combining treatments.

Julian Downward, Principal Group Leader of the Oncogene Biology Laboratory at the Crick, and co-senior author with Miriam Molina-Arcas, said: “Blocking genes like KRAS in lung cancer has led to some exciting new developments, but we still see problems with resistance. We’ve now been able to report partial or complete eradication of tumours in mice by combining KRAS and SHP2 inhibitors with immunotherapy. We also showed that this combination therapy allows ‘immune cold’ tumours to respond to the body’s own defences.”

Panos Anastasiou, PhD student in the Oncogene Biology Laboratory at the Crick, and first author, said: “Our work stresses the importance of targeting tumours from all angles, especially ones that don’t respond easily to treatment. It will be critical to see if the combination of inhibitors works in the same way in humans.”

Panos worked with the Experimental Histopathology, Bioinformatics and Biostatistics, Genomics, Scientific Computing, Flow Cytometry, Cell Services and Biological Resources teams at the Crick. The research was funded by a collaborative research agreement with Revolution Medicines, with additional funding from the European Union and the Wellcome Trust.

-ENDS-

For further information, contact: press@crick.ac.uk or +44 (0)20 3796 5252

Notes to Editors

The newly identified KRAS G12C inhibitor targets the active or ‘ON’ form of KRAS compared with the drugs currently approved for clinical use which target the inactive or ‘OFF’ form of KRAS G12C. Reference: Anastasiou, P. et al. (2024). Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade. Nature Communications. 10.1038/s41467-024-52324-3.

The Francis Crick Institute is a biomedical discovery institute dedicated to understanding the fundamental biology underlying health and disease. Its work is helping to understand why disease develops and to translate discoveries into new ways to prevent, diagnose and treat illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases.

An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King’s College London.

The Crick was formed in 2015, and in 2016 it moved into a brand new state-of-the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under a single roof in Europe.

http://crick.ac.uk/

END



ELSE PRESS RELEASES FROM THIS DATE:

Nanostructures in the deep ocean floor hint at life’s origin

Nanostructures in the deep ocean floor hint at life’s origin
2024-09-25
Researchers led by Ryuhei Nakamura at the RIKEN Center for Sustainable Resource Science (CSRS) in Japan and The Earth-Life Science Institute (ELSI) of Tokyo Institute of Technology have discovered inorganic nanostructures surrounding deep-ocean hydrothermal vents that are strikingly similar to molecules that make life as we know it possible. These nanostructures are self-organized and act as selective ion channels, which create energy that can be harnessed in the form of electricity. Published Sep. 25 in Nature Communications, the findings impact not only our understanding of how life began, but can also ...

Humbug damselfish use 'motion dazzle' to evade predators

2024-09-25
When thinking of animal camouflage, we typically imagine creatures remaining still, blending seamlessly into their surroundings. But remaining motionless isn’t always practical, and many animals are highly mobile, constantly moving through their environment to graze their food. New research suggests that high-contrast patterns on animals’ bodies may serve a dual purpose: offering camouflage when stationary, then creating a ‘motion dazzle’ effect when moving, confusing potential predators into misjudging their location – and helping them avoid being ...

Can a drug-free nasal spray protect against deadly respiratory infections?

2024-09-25
New research published in Advanced Materials reports a novel nasal spray for preventing respiratory infections. The spray works by forming a protective coating on the nasal cavity, which captures airborne respiratory droplets and acts as a physical barrier against viruses and bacteria, while effectively neutralizing them. In studies conducted on mice, the Pathogen Capture and Neutralizing Spray (PCANS) demonstrated up to 8 hours of nasal retention. In a severe Influenza A model, a single pre-exposure dose of PCANS resulted in a greater than 99.99% reduction ...

Do natural disasters jeopardize women’s reproductive health?

2024-09-25
In research published in Brain and Behavior, investigators found increased rates of menstrual irregularities in women living in areas affected by the 2023 earthquake in Turkey. In the study, 309 women of reproductive age living in regions declared as disaster areas completed online forms 9 months after the earthquake. Responses revealed an increase of menstrual irregularities from 14.3% before the earthquake to 44.8% after the earthquake. Risk factors for menstrual irregularities included post-traumatic stress symptoms, chronic diseases, and smoking. The findings reveal that reproductive health ...

Can cosmic radiation in outer space affect astronauts’ long-term cognition?

2024-09-25
During missions into outer space, galactic cosmic radiation (GCR) will penetrate current spacecraft shielding and thus pose a significant risk to human health. Previous studies have shown that GCR can cause short-term cognitive deficits in male rodents. Now a study published in the Journal of Neurochemistry reveals that GCR exposure can also cause long-lasting learning deficits in female rodents. The impact of GCR on cognition was lessened when mice were fed an antioxidant and anti-inflammatory compound called CDDO-EA. Beyond ...

Do preventive health technologies promote or harm consumers’ wellbeing?

2024-09-25
Preventive health technologies—such as wrist-worn activity trackers or health and fitness apps—are popular tools for promoting wellbeing, but new research published in the Journal of Consumer Affairs reveals that consumer engagement with these technologies can be considered a double-edged sword. The study, which involved 30 in-depth interviews with users, found that consumers engage with preventive health technologies based on a variety of health goals—for example, to lose weight, improve performance, monitor data of an enjoyable activity, or acquire a healthy routine. These diverse goals led users ...

Preclinical studies suggest a drug-free nasal spray could ward off respiratory infections

Preclinical studies suggest a drug-free nasal spray could ward off respiratory infections
2024-09-25
Researchers from the Brigham detail how the spray they created may offer broad-spectrum protection from respiratory infections by COVID-19, influenza, everyday cold viruses, and pneumonia-causing bacteria A new study details how a nasal spray formulated by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, may work to protect against viral and bacterial respiratory infections. Based on their preclinical studies, the researchers say the broad-spectrum nasal spray is long-lasting, safe, and, if validated in humans, could play a key role in reducing respiratory diseases ...

Campylobacter jejuni-specific antibody gives hope to vaccine development

Campylobacter jejuni-specific antibody gives hope to vaccine development
2024-09-25
Bacterial infections resulting in enteritis, sometimes extra-intestinal infections such as sepsis, continue to be a global health concern. A leading cause of diarrheal and extra-intestinal infectious mortality among children under 5 and elderly persons is infection with Campylobacter bacteria, against which there is no effective vaccine or medication. An Osaka Metropolitan University-led team has recently uncovered what could be an important step toward preventing, diagnosing, and treating a species of Campylobacter bacteria. Researchers including Professor Shinji Yamasaki and Associate Professor Noritoshi Hatanaka of the Graduate School ...

A viral close-up of HTLV-1

A viral close-up of HTLV-1
2024-09-25
Martin Obr is on edge, anxiously waiting for his train to the airport. A storm called “Sabine” is brewing, shutting down all public transport. He catches his flight from Frankfurt to Vienna just in time. Obr spent the last days in Germany meticulously analyzing what he calls the “perfect sample”. This sample helped him and Florian Schur from the Institute of Science and Technology Austria (ISTA) decode the structure of a virus called HTLV-1 (Human T-cell Leukemia Virus Type 1). In collaboration with the University of Minnesota and Cornell University, ...

Virtual reality can help pedestrians and cyclists swerve harmful pollutants – study

2024-09-25
Physics-informed virtual reality could be key to reducing the exposure of pedestrians and cyclists to harmful, non-exhaust vehicle emissions, according to a study published today (25 Sep) in the Royal Society Open Science journal. The research lead by the University of Birmingham (supported by Rosetrees Trust and Research England QR Funding), targets the issue of major health risks and chronic diseases caused by exposure to unregulated particle pollutants from road, tyre and brake sources by providing easy, accessible guidance to the public, policy makers, and city planners, through immersive VR experiences. Detailed ...

LAST 30 PRESS RELEASES:

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy

Study reveals beneficial microbes that can sustain yields in unfertilized fields

Robotic probe quickly measures key properties of new materials

Climate change cuts milk production, even when farmers cool their cows

Frozen, but not sealed: Arctic Ocean remained open to life during ice ages

Some like it cold: Cryorhodopsins

Demystifying gut bacteria with AI

Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads

Unlocking the hidden biodiversity of Europe’s villages

Planned hydrogen refuelling stations may lead to millions of euros in yearly losses

Planned C-sections increase the risk of certain childhood cancers

Adults who have survived childhood cancer are at increased risk of severe COVID-19

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

T cells take aim at Chikungunya virus

[Press-News.org] Combination treatment improves response to immunotherapy for lung cancer